20 results
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
;
compliance with laws, including anti-corruption and anti-bribery laws;
regulatory matters;
environmental matters;
intellectual property and computer
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
of the Foreign Corrupt Practices Act of 1977, as amended, or any other applicable anti-bribery, anti-corruption, anti-money laundering, record keeping … and internal control Laws, including any such Laws that prohibit private commercial bribery or (iv) made, offered or authorized any other bribe, unlawful rebate
8-K
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
of the Foreign Corrupt Practices Act of 1977, as amended, or any other applicable anti-bribery, anti-corruption, anti-money laundering, record keeping … and internal control Laws, including any such Laws that prohibit private commercial bribery or (iv) made, offered or authorized any other bribe, unlawful rebate
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
with applicable healthcare laws may involve substantial costs. Also, the Foreign Corrupt Practices Act and similar worldwide anti-bribery laws generally
8-K
EX-1.1
PNT
POINT Biopharma Global Inc.
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
on Bribery of Foreign Public Officials in International Business Transactions, and the rules and regulations thereunder and any other similar foreign
S-3
EX-1.2
0cjd1z z1
1 Jul 22
Shelf registration
4:13pm
424B3
wlp0dsnf0kx
31 Mar 22
Prospectus supplement
11:42am
POS AM
tannr6o5t23z knvw8o
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
ia8nhvaqyadii59og1p
5 Aug 21
Prospectus supplement
4:26pm
424B3
1l807q9xsaego
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
mz82rukiz5qp84be3ryp
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
p12w3r0okiq vg78ojk
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
1lgf3g8oxfmz88x1bi
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-1.1
0vwzwff
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm
S-1
EX-1.1
f6spm84kih9sgb0xu
15 Jun 20
IPO registration
5:28pm
- Prev
- 1
- Next